1
|
Divya Bhargavi P, Lolla S, Sugunan S, Shiva Gubbiyappa K, Ali Khan A, Alanazi AM, Vijay Nayak B. The simultaneous quantification of Sitagliptin and Irbesartan in rat plasma using the validated LC-MS/MS method is applied to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1221:123677. [PMID: 36958118 DOI: 10.1016/j.jchromb.2023.123677] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2023] [Revised: 03/04/2023] [Accepted: 03/13/2023] [Indexed: 03/18/2023]
Abstract
Irbesartan (IRB), an angiotensin II receptor AT1 blocker, is an antihypertensive agent commonly used with Sitagliptin (STG), a novel antidiabetic agent in diabetes. A finalised and validated LC-MS/MS method was used for the bioanalytical quantification of STG and IRB to be applicable to studies on the P.K drug-drug interactions between STG and IRB. Using a YMC triart C18 column (50 mm × 4.6 mm i.d., 3 µm), both the drugs and the Tolbutamide were separated using a gradient mode with a flow rate of 1 ml/min with run time of 5 min. For analyte detection, an LC-MS/MS system with multiple reaction monitoring (MRM) was used. The technique was validated across a concentration range of 5-1000 ng/ml, with the LLOQ for both analytes being 5 ng/ml. At all QC levels accuracies from spiked samples were > 83% for both drugs and internal standards. The accuracy for STG within-batch and between-batch was found within 98.4-107.2%, and for IRB was found within 92.4-102.5%. The precision for STG within batch and between batches was less than 12.3% CV, and for IRB was less than 10.2% CV at all concentration levels. The pharmacokinetic profiles of STG and IRB were successfully applied on simultaneous oral administration to rats. This method applies to pharmacokinetic multidrug interaction studies.
Collapse
Affiliation(s)
- P Divya Bhargavi
- Department of Pharmacognosy, JSS College of Pharmacy, Ooty, Tamil Nadu 643001, India
| | - Siddhartha Lolla
- Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Deemed to be University, Hyderabad, Telangana 502032, India; Novel Global Community Educational Foundation, Australia
| | - Sinoy Sugunan
- Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Deemed to be University, Hyderabad, Telangana 502032, India
| | - Kumar Shiva Gubbiyappa
- Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Deemed to be University, Hyderabad, Telangana 502032, India
| | - Azmat Ali Khan
- Pharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
| | - Amer M Alanazi
- Pharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
| | - Bhukya Vijay Nayak
- Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Deemed to be University, Hyderabad, Telangana 502032, India.
| |
Collapse
|
2
|
Nalini CN, Mathivanan N. A Review on Analytical Methods of Irbesartan and its Combinations in Pharmaceutical Dosage Forms. CURR PHARM ANAL 2020. [DOI: 10.2174/1573412915666190802164428] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Pharmaceutical analysis plays an indispensable role in various stages of drug pipeline including
drug development, fabrication of formulation, stability studies and quality control. It is also used for
characterizing the composition of different dosage forms in quantitative and qualitative ways. Comprehensive
literature survey forms the foundation stone for the focused analysis of research activity.
Irbesartan is a hypertension antagonist chiefly employed in the treatment of high blood pressure which
is an Angiotensin II Receptor blocker. The multiple mixtures of various antihypertensive medicaments
raise challenges in the method development and validation. A genuine venture is undertaken to compile
the literatures related to the antihypertensive drug Irbesartan published in various peer reviewed journals.
HPLC and UV spectrophotometry are the most preferred analytical techniques when compared to
other methods. This present review provides an in-depth assortment of various analytical techniques
published for Irbesartan and its combinations, which will help the researchers in their future endeavors.
Collapse
Affiliation(s)
| | - Nivedhitha Mathivanan
- Department of Pharmaceutical Analysis, C.L. Baid Metha College of Pharmacy, Chennai 97, India
| |
Collapse
|
3
|
Darwish IA, Darwish HW, Bakheit AH, Al-Kahtani HM, Alanazi Z. Irbesartan (a comprehensive profile). PROFILES OF DRUG SUBSTANCES, EXCIPIENTS, AND RELATED METHODOLOGY 2020; 46:185-272. [PMID: 33461698 DOI: 10.1016/bs.podrm.2020.07.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Irbesartan, (2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one), is a member of non-peptide angiotensin II receptor antagonists used worldwide in the treatment of hypertension and diabetic nephropathy in hypertensive patients with type 2 diabetes, elevated serum creatinine, and proteinuria. Irbesartan can be used alone or in combination with other antihypertensive agents (e.g., hydrochlorothiazide). These combination products are indicated for hypertension in patients with uncontrolled hypertension with monotherapy or first line in patients not expected to be well controlled with monotherapy. Irbesartan is also indicated for the treatment of diabetic nephropathy in patients with type 2 diabetes and hypertension, an elevated serum creatinine, and proteinuria. Irbesartan exerts its action mainly via a selective blockade action on AT1 receptors and the consequent reduced pressor effect of angiotensin II. This article discusses, by a critical comprehensive review of the literature on irbesartan in terms of its description, names, formulae, elemental composition, appearance, and therapeutic uses. The article also discusses the methods for preparation of irbesartan, its physical-chemical properties, analytical methods for its determination, pharmacological-toxicological properties, and dosing information.
Collapse
Affiliation(s)
- Ibrahim A Darwish
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
| | - Hany W Darwish
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt
| | - Ahmed H Bakheit
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; Department of Chemistry, Faculty of Science and Technology, Al-Neelain University, Khartoum, Sudan
| | - Hamad M Al-Kahtani
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
| | - Zahi Alanazi
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
| |
Collapse
|
4
|
Abstract
Recently, high demand of high-throughput analyses with high sensitivity and selectivity to molecules and drugs in different classes with different physical-chemical properties—and a reduction in analysis time—is a principal milestone for novel methodologies that researchers are trying to achieve—especially when analytical procedures are applied to clinical purposes. In addition, to avoid high doses of a single drug that could cause serious side effects, multi-drug therapies are often used to treat numerous diseases. For these reasons, the demand for methods that allow the rapid analysis of mixed compounds has increased in recent years. In order to respond to these needs, new methods and instruments have been developed. However, often the complexity of a matrix can require a long time for the preparation and processing of the samples. Different problems in terms of components, types of matrices, compounds and physical-chemical complexity are encountered when considering drugs association profiles for quantitative analyses. This review addresses not only recently optimized procedures such as chromatographic separation, but also methods that have allowed us to obtain accuracy (precision and trueness), sensitivity and selectivity in quantitative analyses for cases of drug associations.
Collapse
|
5
|
Smerikarova M, Bozhanov S, Maslarska V. Analytical Methods for the Determination of Sartans in Pharmaceutical Formulations and Biological Fluids: A Review. CURR ANAL CHEM 2020. [DOI: 10.2174/1573411014666181114091850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
Sartans are mostly used as a part of combination with additional medicines
in the therapy of essencial hypertension. Preferred combinations are ARB and thiazide diuretics (Hydrochlorothiazide
(HCT) and Chlorthalidone (CHL)) or ARB and calcium antagonists. The number
of sartans mostly prescribed by specialists is only seven - Candesartan (CDS), Eprosartan (EPS),
Irbesartan (IBS), Losartan (LOS), Olmesartan (OMS), Telmisartan (TMS) and Valsartan (VLS).
Methods:
The widespread use of sartans in the treatment of hypertension requires reliable methods of
analysis. Bulk drugs and pharmaceutical preparations should be analyzed to ensure the quality of the
medicinal products reaching patients. On the other hand, the analysis of drugs in biological fluids
aims to trace and improve patient care by adjusting the therapeutic doses of drugs. According to our
knowledge, a review devoted to the analysis of sartans was published in 2014.
Results:
Spectral methods are widely used in the analysis of bulk drugs and pharmaceutical dosage
forms due to their relatively simple procedures, low reagent and sample consumption, speed, precision
and accuracy combined with accessibility and comparatively low cost of common apparatus.
Many papers for determination of sartans in bulk drugs and pharmaceutical preparations based on
liquid chromatographic techniques were published in the available literature. Among these methods,
HPLC takes the leading place but UPLC and HPTLC are also present.
Conclusion:
The widespread use of sartans in the treatment of hypertension requires reliable methods
of analysis. Bulk drugs and pharmaceutical preparations should be analyzed to ensure the quality
of the medicinal products reaching patients. On the other hand, the analysis of drugs in biological fluids
aims to trace and improve patient care by adjusting the therapeutic doses of drugs. Since 2014,
many articles have been published on the sartans analysis and this provoked our interest to summarize
the latest applications in the analysis of sartans in pharmaceutical formulations and biological
media. Articles published from 2014 to 2018 are covered.
Collapse
Affiliation(s)
- Miglena Smerikarova
- Faculty of Pharmacy, Department of Chemistry, Medical University, Sofia, Bulgaria
| | - Stanislav Bozhanov
- Faculty of Pharmacy, Department of Chemistry, Medical University, Sofia, Bulgaria
| | - Vania Maslarska
- Faculty of Pharmacy, Department of Chemistry, Medical University, Sofia, Bulgaria
| |
Collapse
|
6
|
Comparative Study on Pharmacokinetics of Four Active Compounds in Rat Plasma after Oral Administration of Raw and Wine Processed Chuanxiong Rhizoma. Molecules 2019; 25:molecules25010093. [PMID: 31881790 PMCID: PMC6982718 DOI: 10.3390/molecules25010093] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2019] [Revised: 12/13/2019] [Accepted: 12/23/2019] [Indexed: 12/31/2022] Open
Abstract
In Chinese medicine, the effect of promoting blood circulation and removing stasis could be enhanced after Chuanxiong Rhizoma is processed by wine. However, the relevant mechanism remains unclear. In this manuscript, a rapid and sensitive quantification method employing ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was established and validated to simultaneously determine butylidenephthalide, ligustilide, senkyunolide A and ferulic acid in rat plasma after oral administration of raw Chuanxiong Rhizoma (RCR) and wine-processed Chuanxiong Rhizoma (WCR) respectively. All analytes were extracted from plasma by proteins precipitation with methanol. Chromatographic separation was carried out on a Hypersil GOLD C18 column by using a gradient mobile phase system of acetonitrile and water with 0.01% formic acid, the flow rate was 0.3 mL/min. For exact mass detecting, quick switching mode was used, positive and negative ions could be detected in one injection. The pharmacokinetic profiles of four components in the two groups were evaluated and compared. The results showed that, compared to the RCR group, the Vd and AUC0→t values of four active compounds were increased and decreased respectively in WCR group, which revealed the effect of wine processing to Chuanxiong Rhizoma: the stronger the effect, the wider the distribution.
Collapse
|
7
|
Elgawish MS, Soltan MK, Sebaiy MM. An LC–MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies. J Pharm Biomed Anal 2019; 174:226-234. [DOI: 10.1016/j.jpba.2019.05.069] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Revised: 05/28/2019] [Accepted: 05/30/2019] [Indexed: 10/26/2022]
|
8
|
Ashour S, Bayram R. Selective and validated kinetic spectrophotometric method for the determination of irbesartan in pure and pharmaceutical formulations. ANNALES PHARMACEUTIQUES FRANÇAISES 2018; 77:101-111. [PMID: 30471775 DOI: 10.1016/j.pharma.2018.09.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Revised: 09/05/2018] [Accepted: 09/06/2018] [Indexed: 11/26/2022]
Abstract
A novel-coupling reagent is used for the simple and sensitive kinetic spectrophotometric determination of irbesartan (IRB) in pure or pharmaceutical formulations. The method utilizes an oxidative coupling reaction based on oxidation of 3-methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate (MBTH) with Ce(IV) in 2% sulfuric acid medium, followed by coupling the produced electrophilic intermediate (diazonium salt of the reagent) with IRB to give greenish-blue colored product (1:1, stoichiometry) having maximum absorption at 629nm and the colored species is stable for more than 1h. The initial rate and fixed time (at 35min) methods are adopted for determination of IRB concentration. The linearity is in the ranges of 5.0-40.0μg/mL and 2.0-45.0μg/mL and the limit of detection is 0.46 and 0.40μg/mL for initial rate and fixed time methods, respectively. Molar absorptivity for the method was found to be 1.50×104L/molcm. The validated kinetic methods can be successfully applied to the analysis of IRB in bulk and tablet dosage form and in the routine quality control analysis. The percentage recoveries were above 100% for both methods. The excipients did not interfere in the analysis.
Collapse
Affiliation(s)
- S Ashour
- Department of Chemistry, Faculty of Sciences, Aleppo University, Aleppo, Syria.
| | - R Bayram
- Departments of Pharmaceutical Chemistry, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia
| |
Collapse
|
9
|
Pei Q, Liu JY, Yin JY, Yang GP, Liu SK, Zheng Y, Xie P, Guo CX, Luo M, Zhou HH, Li X, Liu ZQ. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population. Eur J Clin Pharmacol 2018; 74:1021-1028. [DOI: 10.1007/s00228-018-2477-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2017] [Accepted: 05/03/2018] [Indexed: 01/06/2023]
|
10
|
Pandya JJ, Bhatt NM, Chavada VD, Sharma P, Sanyal M, Shrivastav PS. Simultaneous analysis of aliskiren and hydrochlorothiazide in pharmaceutical preparations and spiked human plasma by HPTLC. JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE 2018. [DOI: 10.1016/j.jtusci.2016.05.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Jui J. Pandya
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Nejal M. Bhatt
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Vijay D. Chavada
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Primal Sharma
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Mallika Sanyal
- Department of Chemistry, St. Xavier’s College, Navrangpura, Ahmedabad 380009, India
| | - Pranav S. Shrivastav
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| |
Collapse
|
11
|
Fast and sensitive LC-MS/MS method for the simultaneous determination of lisinopril and hydrochlorothiazide in human plasma. J Pharm Anal 2018. [PMID: 29404033 DOI: 10.1016/j.jpha.2016.11.004.] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
A sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed for the simultaneous determination of lisinopril (LIS) and hydrochlorothiazide (HCTZ) in human plasma using their labeled internal standards (ISs). Sample pre-treatment involved solid phase extraction on Waters Oasis HLB cartridges using 100 µL of plasma, followed by liquid chromatography on Hypersil Gold C18 (50 mm×3.0 mm, 5 µm) column. The analytes were eluted within 2.0 min using acetonitrile-5.0 mM ammonium formate, pH 4.5 (85:15, v/v) as the mobile phase. The analytes and ISs were analyzed in the negative ionization mode and quantified using multiple reaction monitoring. The method showed excellent linearity over the concentration range of 0.50-250.0 ng/mL for both the analytes. The intra-batch and inter-batch precision (% CV) was ≤5.26% and their extraction recoveries were in the range of 96.6%-103.1%. Matrix effect evaluated in terms of IS-normalized matrix factors ranged from 0.97 to 1.03 for both the analytes. The validated method was successfully applied to determine the plasma concentration of the drugs using 10 mg lisinopril and 12.5 mg hydrochlorothiazide fixed dose formulation in 18 healthy Indian volunteers.
Collapse
|
12
|
Fast and sensitive LC-MS/MS method for the simultaneous determination of lisinopril and hydrochlorothiazide in human plasma. J Pharm Anal 2018; 7:163-169. [PMID: 29404033 PMCID: PMC5790688 DOI: 10.1016/j.jpha.2016.11.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Revised: 11/23/2016] [Accepted: 11/24/2016] [Indexed: 01/19/2023] Open
Abstract
A sensitive and rapid liquid chromatography-tandem mass spectrometry (LC–MS/MS) method has been developed for the simultaneous determination of lisinopril (LIS) and hydrochlorothiazide (HCTZ) in human plasma using their labeled internal standards (ISs). Sample pre-treatment involved solid phase extraction on Waters Oasis HLB cartridges using 100 µL of plasma, followed by liquid chromatography on Hypersil Gold C18 (50 mm×3.0 mm, 5 µm) column. The analytes were eluted within 2.0 min using acetonitrile-5.0 mM ammonium formate, pH 4.5 (85:15, v/v) as the mobile phase. The analytes and ISs were analyzed in the negative ionization mode and quantified using multiple reaction monitoring. The method showed excellent linearity over the concentration range of 0.50–250.0 ng/mL for both the analytes. The intra-batch and inter-batch precision (% CV) was ≤5.26% and their extraction recoveries were in the range of 96.6%–103.1%. Matrix effect evaluated in terms of IS-normalized matrix factors ranged from 0.97 to 1.03 for both the analytes. The validated method was successfully applied to determine the plasma concentration of the drugs using 10 mg lisinopril and 12.5 mg hydrochlorothiazide fixed dose formulation in 18 healthy Indian volunteers.
Collapse
|
13
|
Shah JV, Shah PA, Sanyal M, Shrivastav PS. Simultaneous quantification of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Anal 2017; 7:288-296. [PMID: 29404051 PMCID: PMC5790693 DOI: 10.1016/j.jpha.2017.03.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2016] [Revised: 03/06/2017] [Accepted: 03/23/2017] [Indexed: 11/17/2022] Open
Abstract
A selective, sensitive and precise assay based on solid phase extraction and liquid chromatography–tandem mass spectrometry (LC–MS/MS) was developed for the simultaneous determination of amiloride (AMI) and hydrochlorothiazide (HCTZ) in human plasma. Sample clean-up with 250 µL of plasma was done on Phenomenex Strata™-X extraction cartridges using their labeled internal standards (AMI-15N3 and HCTZ-13C,d2). Chromatography was performed on Hypersil Gold C18 (50 mm×3.0 mm, 5 µm) column using acetonitrile with 4.0 mM ammonium formate (pH 4.0, adjusted with 0.1% formic acid) (80:20, v/v) as the mobile phase. Detection was carried out on a triple quadrupole API 5500 mass spectrometer utilizing an electrospray ionization interface and operating in the positive ionization mode for AMI and negative ionization mode for HCTZ. Multiple reaction monitoring was used following the transitions at m/z 230.6/116.0, m/z 233.6/116.0, m/z 296.0/204.9 and m/z 299.0/205.9 for AMI, AMI-15N3, HCTZ and HCTZ-13C,d2, respectively. Calibration curves were linear (r2≥0.9997) over the concentration range of 0.050–50.0 and 0.50–500 ng/mL for AMI and HCTZ, respectively, with acceptable accuracy and precision. The signal-to-noise ratio at the limit of quantitation was ≥14 for both the analytes. The mean recovery of AMI and HCTZ from plasma was 89.0% and 98.7%, respectively. The IS-normalized matrix factors determined for matrix effect ranged from 0.971 to 1.024 for both the analytes. The validated LC–MS/MS method was successfully applied to a bioequivalence study using 5 mg AMI and 50 mg HCTZ fixed dose tablet formulation in 18 healthy Indian volunteers with good reproducibility.
Collapse
Affiliation(s)
- Jaivik V Shah
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Priyanka A Shah
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| | - Mallika Sanyal
- Department of Chemistry, St. Xavier's College, Navrangpura, Ahmedabad 380009, India
| | - Pranav S Shrivastav
- Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad 380009, India
| |
Collapse
|
14
|
Huang Y, Zheng S, Pan Y, Li T, Xu ZS, Shao MM. Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC–MS/MS: Application to their pharmacokinetic interaction study. J Pharm Biomed Anal 2016; 128:184-190. [DOI: 10.1016/j.jpba.2016.05.029] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2016] [Revised: 05/17/2016] [Accepted: 05/18/2016] [Indexed: 11/17/2022]
|
15
|
Bai YL, Yuan HC, Zhang DT, Liu Y, Zhang Y. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 2016; 126:98-102. [DOI: 10.1016/j.jpba.2016.05.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2016] [Revised: 04/27/2016] [Accepted: 05/01/2016] [Indexed: 10/21/2022]
|
16
|
Zhang WL, Lou D, Zhang DT, Zhang Y, Huang HJ. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC–MS/MS method. J Thromb Thrombolysis 2016; 42:205-11. [DOI: 10.1007/s11239-016-1367-y] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
17
|
Zhao AQ, Zhao JH, Zhang SQ, Pan YY, Huo XL. Determination of parthenolide in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal 2016; 119:99-103. [DOI: 10.1016/j.jpba.2015.11.039] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Revised: 11/20/2015] [Accepted: 11/25/2015] [Indexed: 10/22/2022]
|
18
|
Zhang WM, Duan YP, Li W, Qiu JF, Zhang ZY. UPLC-MS-MS Determination of Dihydrocodeine in Human Plasma and Its Application to a Pharmacokinetic Study. J Chromatogr Sci 2015; 54:569-73. [PMID: 26689716 DOI: 10.1093/chromsci/bmv188] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2014] [Indexed: 11/12/2022]
Abstract
A sensitive and rapid ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS-MS) method was developed to determine dihydrocodeine (DHC) in human plasma using diazepam as the internal standard (IS). Sample preparation was accomplished through a liquid-liquid extraction procedure with ethyl acetate. The analyte and IS were separated on an Acquity UPLC BEH C18 column (2.1 × 50 mm, 1.7 μm) with the mobile phase of acetonitrile and 1% formic acid in water with gradient elution at a flow rate of 0.4 mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer equipped with positive-ion electrospray ionization by multiple reaction monitoring (MRM) of the transitions at m/z 302.3 → 199.2 for DHC and m/z 285.1 → 193.1 for IS. The linearity of this method was found to be within the concentration range of 0.5-100 ng/mL with a lower limit of quantification of 0.5 ng/mL. The overall run time was 4.0 min. The method herein described was superior to previous methods and was successfully applied to the pharmacokinetic study of DHC in healthy Chinese volunteers after oral administration.
Collapse
Affiliation(s)
- Wei-min Zhang
- The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, PR China
| | - Yan-pei Duan
- Department of Pharmacy, Xinxiang Central Hospital, Xinxiang, Henan 453000, PR China
| | - Wei Li
- The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, PR China
| | - Jian-fei Qiu
- Medical College of Henan University of Science and Technology, Luoyang, Henan 471003, PR China
| | - Zhi-yin Zhang
- Medical College of Henan University of Science and Technology, Luoyang, Henan 471003, PR China
| |
Collapse
|
19
|
Pan C, Chen Y, Chen W, Zhou G, Jin L, Zheng Y, Lin W, Pan Z. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 1008:255-259. [PMID: 26684720 DOI: 10.1016/j.jchromb.2015.11.056] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2015] [Revised: 11/27/2015] [Accepted: 11/30/2015] [Indexed: 02/06/2023]
Abstract
In this work, a rapid and sensitive ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for the determination of ledipasvir, sofosbuvir and its metabolite GS-331007 in rat plasma was developed. The analytes and the internal standard (diazepam) were separated on an Acquity UPLC BEH C18 chromatography column (2.1mm×50mm, 1.7μm) using gradient elution with a mobile phase of acetonitrile and 0.1% formic acid in water at a flow rate of 0.4mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM) mode to monitor the precursor-to-product ion transitions of m/z 889.8→130.1 for ledipasvir, m/z 530.3→243.1 for sofosbuvir, m/z 261.5→113.1 for GS-331007 and m/z 285.2→193.1 for diazepam (IS) using a positive electrospray ionization interface. The method was validated over a concentration range of 2-500ng/mL for ledipasvir, 10-2000ng/mL for sofosbuvir and 10-2000ng/mL for GS-331007. Total time for each chromatography was 3.0min. The intra- and inter-day precision and accuracy of the quality control samples at low, medium, and high concentration levels exhibited relative standard deviations (RSD)<10.2% and the accuracy values ranged from -9.8% to 11.2%. The method was successfully applied to a pharmacokinetic study of ledipasvir, sofosbuvir and GS-331007 in rats.
Collapse
Affiliation(s)
- Chenwei Pan
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Yongping Chen
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
| | - Weilai Chen
- Wenzhou People's Hospital, Wenzhou 325027, China
| | - Guangyao Zhou
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Lingxiang Jin
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Yi Zheng
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Wei Lin
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
| | - Zhenzhen Pan
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
| |
Collapse
|
20
|
Patel TR, Patel TB, Suhagia BN, Shah SA. HPTLC Method for Simultaneous Estimation of Aliskiren, Amlodipine, and Hydrochlorothiazide in Synthetic Mixture Using Quality by Design Approach. J LIQ CHROMATOGR R T 2015. [DOI: 10.1080/10826076.2015.1076461] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Tushar R. Patel
- Faculty of Pharmacy, Dharmsinh Desai University, Gujarat, India
| | - Tejas B. Patel
- Faculty of Pharmacy, Dharmsinh Desai University, Gujarat, India
| | | | | |
Collapse
|
21
|
Wang XJ, Hu W, Zhang TY, Mao YY, Liu NN, Wang SQ. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. Antiviral Res 2015; 120:140-6. [PMID: 26086883 DOI: 10.1016/j.antiviral.2015.06.007] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 05/04/2015] [Accepted: 06/14/2015] [Indexed: 02/06/2023]
Abstract
The liver-specific Na(+)-dependent taurocholate cotransporting polypeptide (NTCP) was recently identified as an entry receptor for hepatitis B virus (HBV) hepatotropic infection. In this study, an NTCP-overexpressing HepG2 cell line named HepG2.N9 susceptible to HBV infection was established using transcription activator-like effector nucleases (TALEN) technology. Using this cell line, irbesartan, the new NTCP-interfering molecule reported recently, was demonstrated here to effectively inhibit HBV infection with an IC50 of 3.3μM for hepatitis B e antigen (HBeAg) expression and exhibited no obvious cytotoxicity up to 1000μM. Irbesartan suppressed HBV uptake weakly but inhibited HBV covalently closed circular DNA (cccDNA) formation efficiently at physiological temperature. These results suggested that irbesartan targeted HBV infection at a post-uptake prior to cccDNA formation step such as the cell membrane fusion. Based on these findings, irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, could be a potential candidate for treatment of HBV infection although further in vivo experiments are required.
Collapse
Affiliation(s)
- Xue-jun Wang
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
| | - Wei Hu
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
| | - Ting-yu Zhang
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
| | - Ying-ying Mao
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
| | - Nan-nan Liu
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
| | - Sheng-qi Wang
- Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
| |
Collapse
|
22
|
Lotfy HM, Hegazy MA, Mowaka S, Mohamed EH. Novel spectrophotometric methods for simultaneous determination of Amlodipine, Valsartan and Hydrochlorothiazide in their ternary mixture. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2015; 140:495-508. [PMID: 25638433 DOI: 10.1016/j.saa.2014.12.096] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2014] [Revised: 12/15/2014] [Accepted: 12/28/2014] [Indexed: 06/04/2023]
Abstract
This work represents a comparative study of two smart spectrophotometric techniques namely; successive resolution and progressive resolution for the simultaneous determination of ternary mixtures of Amlodipine (AML), Hydrochlorothiazide (HCT) and Valsartan (VAL) without prior separation steps. These techniques consist of several consecutive steps utilizing zero and/or ratio and/or derivative spectra. By applying successive spectrum subtraction coupled with constant multiplication method, the proposed drugs were obtained in their zero order absorption spectra and determined at their maxima 237.6 nm, 270.5 nm and 250 nm for AML, HCT and VAL, respectively; while by applying successive derivative subtraction they were obtained in their first derivative spectra and determined at P230.8-246, P261.4-278.2, P233.7-246.8 for AML, HCT and VAL respectively. While in the progressive resolution, the concentrations of the components were determined progressively from the same zero order absorption spectrum using absorbance subtraction coupled with absorptivity factor methods or from the same ratio spectrum using only one divisor via amplitude modulation method can be used for the determination of ternary mixtures using only one divisor where the concentrations of the components are determined progressively. The proposed methods were checked using laboratory-prepared mixtures and were successfully applied for the analysis of pharmaceutical formulation containing the cited drugs. Moreover comparative study between spectrum addition technique as a novel enrichment technique and a well established one namely spiking technique was adopted for the analysis of pharmaceutical formulations containing low concentration of AML. The methods were validated as per ICH guidelines where accuracy, precision and specificity were found to be within their acceptable limits. The results obtained from the proposed methods were statistically compared with the reported one where no significant difference was observed.
Collapse
Affiliation(s)
- Hayam M Lotfy
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562 Cairo, Egypt
| | - Maha A Hegazy
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562 Cairo, Egypt
| | - Shereen Mowaka
- Analytical Chemistry Department, Faculty of Pharmacy, British University in Egypt, 11837 El-Sherouk City, Egypt; Analytical Chemistry Department, Faculty of Pharmacy, Helwan University, Ein Helwan, 11795 Cairo, Egypt
| | - Ekram Hany Mohamed
- Analytical Chemistry Department, Faculty of Pharmacy, British University in Egypt, 11837 El-Sherouk City, Egypt.
| |
Collapse
|